Red Light Therapy for Horses and the Placebo Question: Why Your Horse Cannot Believe the Light Into Working — But You Can Fool Yourself Into Thinking It Did
Share
We sell red light therapy devices for horses, and we are going to address the placebo question head-on — because the owners who doubt are the ones we respect most, and the answer is more interesting than either side of the argument usually admits. The single strongest argument against placebo in equine photobiomodulation is the horse itself. Your horse has no expectations. It did not read the product page. It does not know what the device cost. It has no concept of "therapy" and no belief that the glowing pad on its back is supposed to help. If a wound closes measurably, if a gait score improves on veterinary assessment, if the horse moves differently after eight weeks of consistent application — the horse did not believe the light into producing those outcomes. The cellular mechanism either fired or it did not. The tissue either responded or it did not. The horse did not cooperate by wishing itself better.
But here is the second point — and it is the one that most people selling devices do not want to say: the horse cannot have placebo, but you can have observer bias, and observer bias looks exactly like placebo from the outside. You spent money on a device. You want it to work. You apply it daily and watch for changes. When the horse seems slightly less stiff one morning, you attribute it to the therapy rather than to the warmer weather, the different footing, or the normal variation that every horse shows day to day. When the wound closes at a normal rate, you credit the device rather than the horse's immune system doing what it was going to do anyway. This is not dishonesty — it is human perception working exactly as it always does when we are looking for a pattern we want to find. Understanding the difference between what the horse experiences and what you perceive is the key to evaluating red light therapy honestly. For the cellular science behind how PBM actually works at the molecular level, our guide to how photobiomodulation works covers the pathway from photon absorption to tissue response.
And the third point positions the evidence where it actually stands: the mechanism of photobiomodulation is well-characterised, the in vitro evidence is strong, the controlled animal studies are promising, and the equine-specific evidence is real but still developing. This is not a therapy that was invented by marketing. It is a photochemical process that has been studied for over fifty years. But it is also not a therapy where the equine clinical evidence is as deep, as controlled, or as condition-specific as the marketing sometimes implies. Both of those things are true at the same time — and holding both of them honestly is how you make a good decision about whether to use it on your horse.
The Short Answer
Horses cannot have a placebo response. The therapy either produces a cellular effect or it does not — independent of the horse's beliefs, which do not exist.
But: the owner can have observer bias — expecting the therapy to work and interpreting ambiguous changes as improvement. This is real, common, and not the same as the horse having placebo.
The evidence: in vitro cell studies show measurable PBM effects (cells cannot have placebo). Controlled animal studies show measurable differences between treated and sham groups. The mechanism (CCO → ATP → NO) is well-characterised. The equine-specific clinical evidence is real but still developing.
Your defence against your own bias: systematic tracking — baseline photos, weekly notes, day 30 evaluation against recorded evidence, not against memory.
Why Horses Cannot Have a Placebo Response
What placebo actually requires
The placebo effect, in its clinical definition, requires a subject to have an expectation that a treatment will work — and that expectation itself produces a measurable physiological or psychological change. In human medicine, this is powerful: patients given inert sugar pills report pain relief, mood improvement, and symptom reduction because they believe they are receiving medication. The belief drives the response.
Horses do not have this capacity. They lack the cognitive framework to:
- Understand that a therapy is being applied. The horse knows a pad is on its back. It does not know the pad contains LEDs emitting 660 nm and 850 nm photons targeting cytochrome c oxidase.
- Form an expectation of benefit. The horse has no concept of "this is supposed to help my arthritis."
- Associate the device with a future outcome. The horse may associate the routine with treats, attention, or standing quietly — but not with cellular repair or pain relief.
- Report subjective improvement. The horse cannot tell you it feels better. All equine assessments are based on observed behaviour, measured gait, or clinical findings — not self-report.
This is the strongest argument for taking equine PBM seriously
When a researcher or a sceptic asks "how do you know it's not placebo?" about a human PBM study, the question is legitimate — human subjects can have genuine placebo responses that confound the results. When the same question is asked about an equine study, the answer is structural: the species cannot produce the effect being asked about.
A horse that warms up two minutes faster after six weeks of PBM did not choose to warm up faster because it believed in the therapy. A wound that closes 15 percent faster in a treated group versus a sham group did not close faster because the horses in the treated group expected healing. If the outcome is measured objectively — wound area in square centimetres, gait score on a lameness scale, collagen fibre organisation on histology — the placebo explanation does not apply to the horse.
It may still apply to the observer. But that is a different problem.
The Observer Bias Problem: Where the "Placebo" Actually Lives
If the horse cannot have placebo, where does the sceptic's concern actually point? It points at you — the owner.
How observer bias works in equine PBM
| What happens | What you conclude | What may actually be occurring |
|---|---|---|
| The horse seems slightly less stiff one morning | "The therapy is working" | Normal day-to-day variation. Horses have good days and bad days regardless of therapy. Warmer weather, different footing, more turnout time, or natural healing trajectory |
| A wound closes over 4–6 weeks | "The red light healed it faster" | Wounds heal. The question is whether this wound healed faster than it would have without PBM — and without a baseline measurement and a comparison, you cannot answer that |
| The horse seems more comfortable during sessions | "The light is relieving pain" | The horse is standing quietly because you are giving it attention, treats, and a calm routine — not necessarily because the light is producing an analgesic effect |
| After 8 weeks, the horse "seems better overall" | "Red light therapy works" | "Seems better" is an impression, not a measurement. Without a recorded baseline and specific tracked observations, this conclusion is unfalsifiable — you cannot disprove your own feeling |
Observer bias is not dishonesty
Observer bias is not lying to yourself. It is the natural consequence of human perception: when you are looking for a pattern, you find one — even in noise. When you have invested money, time, and hope in a therapy, your brain will preferentially notice evidence that supports the decision and underweight evidence that contradicts it. This is confirmation bias, and it operates in every domain of human life, not just equine therapy. Acknowledging it does not mean the therapy does not work. It means that your unstructured impression of whether the therapy works is not reliable evidence. Something more systematic is needed.
The Three Tiers of Evidence That Eliminate Placebo
If the placebo question is really "does photobiomodulation produce a real cellular effect, or is it all in the mind?" — the answer has been established at three levels, each of which progressively eliminates the placebo explanation.
Tier 1: In vitro cell studies — placebo impossible
When fibroblasts, osteoblasts, chondrocytes, or other cell types are exposed to red and near-infrared light in a controlled laboratory setting, measurable changes occur: altered mitochondrial membrane potential, increased ATP production, modulated reactive oxygen species, enhanced collagen synthesis, changed gene expression profiles. A systematic review of PBM effects on dermal fibroblasts in vitro confirmed therapeutically significant effects across multiple domains — cellular viability, proliferation, migration, ATP function, and protein synthesis.
Cells in a petri dish cannot have a placebo response. They have no expectations, no beliefs, and no awareness. If the ATP production increases when light hits cytochrome c oxidase, the mechanism is real. The debate is not whether the photochemistry works — it is whether the photochemistry translates to clinically meaningful outcomes in living, complex organisms at the doses achievable through the skin.
Tier 2: Controlled animal studies — placebo structurally excluded
Blinded, sham-controlled studies in animals — including equine subjects — have demonstrated measurable differences between treated and untreated groups. In these designs, one group receives the active PBM device while the control group receives a sham device (identical in appearance, weight, and mild warmth, but emitting no therapeutic light). The animals do not know which group they are in. The evaluators often do not know either (double-blinded).
When the treated group shows accelerated collagen fibre organisation in healing tendons, reduced inflammatory infiltrate, or faster wound closure compared to the sham group, the explanation cannot be placebo — the animals had no awareness of which device they received.
Tier 3: Randomised controlled human trials
Double-blinded, placebo-controlled human studies — where subjects receive either a real or sham PBM device and neither they nor the assessors know which — have shown statistically significant effects for specific applications. A randomised trial of PBM combined with endurance training showed a "possibly positive" effect on running performance and reduced muscle soreness compared to placebo. Multiple systematic reviews have found positive effects of PBM on delayed-onset muscle soreness, wound healing, and pain management in controlled settings.
The human evidence is the most debated because human trials are harder to control and the effect sizes for some applications are modest. But combined with the in vitro evidence (no placebo possible) and the animal evidence (placebo structurally excluded), the picture is clear: PBM produces a real photochemical effect. The remaining questions are about dose, application, and which clinical conditions benefit most — not about whether the fundamental mechanism is real.
What the Equine Evidence Actually Shows — Honestly
We are a company that sells equine PBM devices, and here is where we think the evidence stands. We are not going to overstate it.
| Evidence category | Strength | What it shows |
|---|---|---|
| Cellular mechanism (CCO, ATP, NO) | Strong | Well-characterised in multiple cell types across species. Not disputed by serious researchers. The photochemistry is real |
| In vitro PBM on equine cells | Strong | Equine fibroblasts, tenocytes, and other cell types respond to red and NIR light in controlled settings. Species-specific confirmation of the mechanism |
| Controlled equine tendon/wound studies | Promising but limited | Several studies show improved collagen organisation and healing metrics. Some studies show no significant acceleration, particularly for experimental skin wounds under specific protocols |
| Clinical field observations (uncontrolled) | Widespread but low-quality evidence | Thousands of owners and practitioners report positive outcomes. Valuable as real-world signal but vulnerable to observer bias and confounding factors |
| Large-scale, multi-centre equine RCTs | Still lacking | The equine-specific clinical evidence has not yet reached the depth of human PBM research. More controlled, condition-specific equine trials are needed |
What "evidence is still developing" actually means
"Evidence is still developing" does not mean "no evidence." It means the research has not yet produced enough large, controlled, equine-specific clinical trials to make definitive claims about every condition. The mechanism is established. The in vitro effects are confirmed. The controlled animal studies are promising. What is missing is the volume and depth of condition-specific equine trials that would let us say, with full confidence, "PBM accelerates equine tendon healing by X percent at Y dose" for each condition.
This is an honest characterisation. It is not a reason to dismiss the therapy. It is a reason to approach it as a well-supported modality with a strong mechanistic basis rather than as a proven cure — and to use systematic tracking to evaluate whether it is working for your horse.
The Conditions Where Placebo Is Easiest and Hardest to Claim
Not all equine applications are equally vulnerable to the observer bias problem. Some produce outcomes that are measurable, objective, and difficult to fake. Others produce outcomes that are subjective, gradual, and easy to misattribute.
| Application | How measurable is the outcome? | Placebo/bias vulnerability |
|---|---|---|
| Wound healing | Highly measurable — photograph, measure area in cm², track closure rate | Low. A wound either closed faster or it did not. Photos with a ruler do not lie. This is one of the easiest applications to evaluate objectively |
| Gait improvement (veterinary assessment) | Measurable — lameness grading scales, gait analysis, flexion tests | Low-moderate. If assessed by a blinded vet who does not know whether PBM was applied, the evaluation is objective. If assessed by the owner who applied the therapy, bias is possible |
| Post-exercise recovery speed | Moderately measurable — time to return to baseline stiffness, next-day soreness assessment | Moderate. Measurable if tracked consistently over weeks with comparison data. Vulnerable to day-to-day variation if not tracked |
| "Seems more comfortable" | Subjective — relies on owner interpretation of behaviour | High. This is the observation most vulnerable to bias. "Seems more comfortable" can mean anything and is unfalsifiable without specific, recorded observations |
| "Seems happier / more willing" | Subjective | High. Same as above. Valuable as a personal observation but not evidence of PBM efficacy |
Why we focus on specific conditions in our guides
Across our blog, we write condition-specific guides — girth galls, proud flesh, DDFT injuries, sweet itch, hoof cracks — rather than making broad "red light therapy helps everything" claims. Each guide evaluates whether the specific condition's biology matches what PBM can deliver. Sometimes the answer is yes (girth galls — accessible skin wound in active repair). Sometimes the answer is no (hoof cracks — dead keratin, no living cells). Condition-specific honesty is the antidote to the kind of overpromising that fuels the placebo accusation in the first place.
Your Defence Against Your Own Bias: The Tracking System
If the horse cannot have placebo but you can have observer bias, the practical solution is a system that removes your subjective impression from the evaluation. We have written an entire guide on this — how to track your horse's progress with red light therapy — and the core of it applies directly to the placebo question:
- Baseline before session one. A photograph with a ruler (wounds), a timed warm-up, a gait video, a specific palpation response. Recorded and dated.
- Weekly observation. Same measurement, same conditions, two sentences in your notes app. Not an impression — a specific, comparable observation.
- Evaluation at day 30 and day 60. Compare the current evidence against the recorded baseline. Not against what you hoped. Not against what you remember. Against the photograph, the video, the number.
If the wound is 30 percent smaller in the day-30 photograph than in the day-one photograph, that is not your bias — that is a photograph. If the warm-up decreased from twelve minutes to eight minutes by the clock, that is not an impression — that is a number. Observer bias lives in the gap between evidence and memory. A tracking system closes that gap.
The inverse is also true: if 60 days of consistent, properly applied PBM produces no measurable change in the tracked observation, the honest conclusion is that either the condition does not respond to PBM, or the application parameters need review. The tracking system protects you from both false positives (thinking it worked when it did not) and false negatives (quitting too early without enough data).
What About the "Handling Effect"?
One nuance worth acknowledging: some of what horse owners observe during PBM sessions — the horse lowering its head, licking and chewing, becoming calm and relaxed — may partly be a response to the handling, attention, and routine rather than to the light itself. The horse is standing quietly, receiving contact, in a calm environment. These are relaxation cues that have nothing to do with photobiomodulation.
This is not a criticism of PBM — it is a recognition that the therapeutic experience includes more than just the photons. A horse that associates the therapy routine with calm, positive handling may genuinely stand more quietly and show relaxation behaviours without the light producing them. The light may still be producing cellular effects underneath — but the behavioural signs the owner sees may be partly or entirely handling-mediated.
In controlled studies, this is handled by the sham group: both groups receive identical handling and device application, but only one group receives therapeutic light. Differences between the groups can then be attributed to the light, not the handling. In your barn, you cannot run a sham control. But you can be aware that your horse's relaxation during a session is not proof that the therapy is working at the cellular level — it is proof that your horse likes standing quietly while you give it attention.
Why the Placebo Accusation Persists — and Why It Partly Should
Why it persists
- Overpromising by device marketers. When companies claim their device treats everything from arthritis to anxiety to hoof quality to immune function, the breadth of the claims triggers justified scepticism. Our own guides address this by being specific about where PBM fits and where it does not.
- Uncontrolled testimonials as evidence. "My horse seemed better after six weeks" is a data point, not evidence. The equine PBM community relies heavily on testimonials, which are the evidence type most vulnerable to observer bias.
- Insufficient equine-specific controlled trials. The mechanism is established, but the condition-specific equine evidence is thinner than the marketing suggests. This creates a gap that sceptics reasonably question.
Why it partly should persist
Healthy scepticism serves horse owners. A buyer who asks "is this just placebo?" is a buyer who will demand evidence, track results, and evaluate honestly — and those are the buyers who get the most value from the therapy when it works, and redirect their resources when it does not. We would rather sell to a sceptic who tracks results than to a true believer who never questions whether the therapy is doing what they think it is doing.
The honest position for a company that sells PBM devices: the cellular mechanism is real, the in vitro evidence is strong, the controlled animal evidence is promising, and the equine-specific clinical evidence is developing. We sell devices because we believe the mechanism and the evidence support real therapeutic value for specific equine conditions. We also believe that systematic tracking, condition-specific honesty, and respect for the limits of current evidence serve our customers better than uncritical marketing. If the therapy works for your horse, the evidence will show it. If it does not, you deserve to know that too.
Conclusion: The Horse Cannot Placebo — But You Need to Prove It to Yourself
Your horse cannot have a placebo response. It has no expectations, no awareness of therapy, and no belief that the glowing pad on its back is supposed to help. If a wound closes measurably, if a gait improves on veterinary assessment, if collagen organises differently in treated tissue versus untreated tissue — the horse did not cooperate by believing. The mechanism either fired or it did not.
You, however, can have observer bias — and it looks exactly like results. You expect improvement. You interpret ambiguous changes as progress. You credit the device for outcomes that might have occurred without it. This is not dishonesty; it is how human perception works when investment and hope are involved.
The evidence base eliminates placebo at the mechanistic level. Cells respond to red and near-infrared light. The ATP production increases. The NO displaces from cytochrome c oxidase. The inflammation modulators shift. These are measured, repeatable, photochemical events — not beliefs. The remaining question is whether those cellular events translate to clinically meaningful outcomes in your horse, for your condition, at the dose your device delivers. And that question is best answered not by argument but by evidence — your evidence, from your horse.
Take the baseline photo. Write the weekly note. Evaluate at day 30 against recorded evidence. If the therapy works, the tracking will show it. If it does not, the tracking will show that too. And either way, you will have answered the placebo question for yourself — with evidence instead of hope.
Frequently Asked Questions
Is red light therapy for horses just a placebo?
Horses cannot have a placebo response in the clinical sense. Placebo requires expectation — a subject must believe a treatment is being given and expect it to help. Horses have no awareness that a therapy is being applied, no expectation of benefit, and no knowledge that the device costs money or that you read promising testimonials before buying it. If a wound closes measurably, if a gait score improves on veterinary assessment, if inflammatory markers change in bloodwork, the horse did not believe the light into producing those outcomes. The cellular mechanism — cytochrome c oxidase absorbing photons and triggering ATP production — occurs regardless of what the horse believes, feels, or thinks. However, the owner can have observer bias, which is different from the horse having placebo. You expect the therapy to work, you interpret ambiguous changes as improvement, and you attribute coincidental healing to the device. This is a real and common problem in equine PBM — but it is a bias in the observer, not a placebo in the horse.
Can animals have a placebo response?
Animals can exhibit something called the caregiver placebo effect or placebo-by-proxy, in which the owner or caregiver perceives improvement in the animal because they expect the treatment to work — even when no objective change has occurred. This is observer bias, not a true placebo response in the animal. The animal itself does not have the cognitive framework to expect or believe in a treatment. Some researchers have also noted that the handling, attention, and routine associated with administering a therapy may produce a calming effect on the animal — the horse stands quietly, receives contact, and relaxes during the session — which the owner may interpret as therapeutic improvement. This is a real behavioural effect of the handling, not a placebo response to the light. Separating the effect of the light from the effect of the attention is one of the challenges in uncontrolled animal therapy observations, which is why controlled studies with sham (inactive device) groups are important.
What is the evidence that photobiomodulation works beyond placebo?
The evidence base for photobiomodulation includes three tiers that progressively eliminate the possibility of placebo. First, in vitro cell studies: when fibroblasts, osteoblasts, or other cells are exposed to 660 nm or 810–850 nm light in a controlled laboratory setting, measurable changes occur — increased ATP production, altered mitochondrial membrane potential, modulated inflammatory markers, enhanced collagen synthesis. Cells in a petri dish cannot have a placebo response. Second, controlled animal studies: blinded, sham-controlled studies in animals (including equine subjects) have demonstrated measurable differences between treated and untreated groups in wound healing rates, collagen organisation, and inflammatory markers. Third, randomised controlled human trials: double-blinded, placebo-controlled studies in humans (using sham devices identical in appearance but producing no therapeutic light) have shown statistically significant effects for specific applications including post-exercise muscle recovery, wound healing, and joint pain. The mechanism — photon absorption by cytochrome c oxidase, NO displacement, ATP production increase — is well-characterised at the molecular level. The therapy is not a belief system; it is photochemistry.
How do I know if red light therapy is actually working on my horse or if I am just seeing what I want to see?
This is the most important practical question in the entire placebo discussion, and the answer is systematic tracking. Before your first session, record a baseline: a photograph, a gait video, a specific observation (warm-up time in minutes, wound dimensions with a ruler in the photo, palpation response at a specific point on the back). Then record the same observation weekly under the same conditions. At day 30 and day 60, compare your current observations against the baseline — not against your hopes or your memory, but against the recorded evidence. If the wound is measurably smaller in the photographs, that is not your bias — that is a photograph. If the warm-up time decreased from twelve minutes to eight minutes by the clock, that is not an impression — that is a number. Observer bias operates in the space between evidence and memory. A systematic tracking protocol with photographs, measurements, and specific time-stamped observations removes most of that space.
Why do some horse owners say red light therapy did not work for them?
There are several honest reasons why an owner may not see results, none of which prove the therapy is placebo. First, the condition may not respond to PBM. Structural problems (mature scar tissue, hoof cracks in dead keratin), active infections (bacterial, fungal), and allergic conditions do not respond because the underlying problem is not one that cellular stimulation addresses. Second, the application may have been inadequate — wrong area, insufficient session length, poor device contact, or power density too low to reach the target tissue. Third, and most commonly, the owner was inconsistent. Sporadic use does not produce cumulative cellular effects. A device used eight times in thirty days has not been given a fair trial at a daily protocol. Fourth, the owner evaluated too early — quitting at week two before the four-to-eight-week window where meaningful changes typically emerge. And fifth, the owner had no baseline, so even if improvement occurred gradually, daily observation made it invisible. Failed outcomes deserve honest diagnosis before being attributed to the therapy being fake.
